Boc-L-Dap(Aloc)-OH*DCHA

Boc-L-Dap(Aloc)-OH*DCHA is a protected lysine-side-chain amino acid building block designed for controlled peptide assembly, featuring a Boc-protected amino group and an Aloc (allyloxycarbonyl) protecting group on the side-chain amine. The DCHA counterion form supports handling and formulation in peptide chemistry workflows where protected, cation-associated amino acid derivatives are commonly used. With orthogonal protection relative to Boc, this reagent is used to enable selective deprotection and subsequent functionalization during multi-step peptide synthesis and peptide library construction.

1. Orthogonal Peptide Synthesis

Boc-L-Dap(Aloc)-OH*DCHA is used by peptide synthesis groups to build peptides containing a protected lysine side chain with a handle for later, selective side-chain modification. The Boc group provides reliable N-terminal protection under standard peptide coupling and deprotection conditions, while the Aloc protecting group enables stepwise control over the side-chain amine reactivity. This makes the reagent practical for workflows that require sequential deprotection events to install different substituents at the lysine side chain without disturbing other protected sites.

2. Peptide Library Side-Chain Diversification

Boc-L-Dap(Aloc)-OH*DCHA supports peptide library development where lysine side-chain diversity is introduced late in the synthesis sequence. Researchers in medicinal chemistry and chemical biology often use this kind of orthogonally protected amino acid derivative to generate series of analogs by selectively unmasking the side-chain amine and coupling it to distinct acyl, carbamate, or other nitrogen-containing substituents. The protected starting material format helps maintain uniformity across library members during early chain assembly, while enabling controlled divergence at the Dap side chain.

3. Pharmaceutical Intermediate Building Block

Boc-L-Dap(Aloc)-OH*DCHA is also employed as a pharmaceutical intermediate in the preparation of protected Dap-containing fragments used for downstream synthesis of peptidomimetics and related nitrogen-rich intermediates. Process development and custom synthesis teams value the defined protection pattern because it supports predictable functional group management across multi-step routes, particularly when side-chain amine availability must be introduced at a specific stage. The DCHA salt form is commonly leveraged to improve practical handling of the protected amino acid derivative during manufacturing-scale intermediate preparation and purification planning.

4. Controlled Post-Synthetic Modification

Boc-L-Dap(Aloc)-OH*DCHA is used in chemical biology and protein chemistry research to enable controlled post-synthetic modification strategies on lysine-containing peptide constructs. By incorporating the protected Dap unit during peptide assembly, researchers can later trigger selective side-chain amine unmasking and perform subsequent derivatization steps on the peptide scaffold. This approach is frequently chosen when the modification chemistry must be spatially restricted to a specific lysine site while preserving other functional groups introduced earlier in the synthesis sequence.

1. An interdomain binding site on HIV-1 Nef interacts with PACS-1 and PACS-2 on endosomes to down-regulate MHC-I

2. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function

3. Effect of Probiotic Lactobacillus plantarum on Streptococcus mutans and Candida albicans Clinical Isolates from Children with Early Childhood Caries

4. Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis

5. P-selectin and Complement’s Role in a Neonatal Model of Germinal Matrix Hemorrhage-Induced Secondary Injury